The Effect of Contrast Agent on Endothelial Function in Healthy Men
1 other identifier
interventional
60
1 country
1
Brief Summary
Contrast medium is essential for diagnosis of many diseases. However, recent studies showed that contrast agents can induce renal injury and is associated with poor long-term clinical outcome, especially in diabetes. To date, no data are available on the relationship between contrast medium and endothelial function. Endothelial dysfunction is known to precede atherosclerosis and is considered a risk marker for future development of cardiovascular disease. Therefore, we hypothesized that contrast agents may induce endothelial dysfunction in healthy men. In addition, we hypothesized that contrast induced endothelial dysfunction via free radicals. Thus, we also test alpha-lipoic acid whether or not protect endothelial dysfunction induced by contrast agents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jul 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 4, 2013
CompletedFirst Posted
Study publicly available on registry
July 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedAugust 13, 2015
August 1, 2015
2 years
July 4, 2013
August 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The endothelial dysfunction and the protective role of alpha-lipoic acid
6 months
Secondary Outcomes (1)
The apoptosis of endothelial progenitor cell
6 months
Study Arms (3)
contrast group (Ioversol)
EXPERIMENTALEach individual will be given 80 ml Ioversol via intravenous injection within 5 minutes
Placebo group
PLACEBO COMPARATORalpha-lipoic acid group
OTHERAlpha-lipoic acid 600 mg in 0.9% sodium chloride 250 ml was administrated 1 hour before contrast agents via venous. and only 0.9% sodium chloride 250 ml was administrated for other 2 groups.
Interventions
Eligibility Criteria
You may qualify if:
- healthy men
- yr \< = age \< = 30 yr
- \< = body mass index \< = 25
You may not qualify if:
- age \< 20 yr or \> 30 yr
- dysfunction for liver, renal, and heart.
- other diseases such as diabetes, hypertension, thyroid disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xiang Guang-dalead
Study Sites (1)
Wuhan General Hospital
Wuhan, Hubei, 430070, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Endocrinol and Metab
Study Record Dates
First Submitted
July 4, 2013
First Posted
July 10, 2013
Study Start
July 1, 2013
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
August 13, 2015
Record last verified: 2015-08